Retatrutide Supplier Checklist: COA Verification & UAE Delivery

What Is Retatrutide?

Retatrutide (LY-3437943) is an investigational triple-agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCGR (glucagon receptor). In other words, it targets all three receptor systems rather than one or two, which is why the research literature often compares it with single-agonist compounds like semaglutide and dual-agonist compounds like tirzepatide. In published analyses, its investigational profile is discussed in relation to metabolic health, blood-sugar regulation, appetite signalling, fat metabolism, and energy expenditure, with glucagon-receptor activation described as a proposed contributor to a higher resting metabolic rate. These are research-literature descriptions of an investigational compound, not therapeutic claims.

In a Phase 2 trial published in the New England Journal of Medicine, retatrutide reported a 24.2% mean body-weight endpoint in the highest study arm over 48 weeks — alongside separate trial datasets in which semaglutide reported roughly 10–15% and tirzepatide over 20% mean body-weight reductions. The pivotal Phase 3 TRIUMPH-1 obesity trial reported positive topline results on May 21, 2026: 28.3% mean body-weight change at 80 weeks on 12 mg (up to 30.3% at 104 weeks in a BMI ≥35 extension). Published trial analyses also discuss appetite suppression, reduced food intake, significant fat loss, and reductions in visceral fat as reported research endpoints. Eli Lilly’s broader TRIUMPH and TRANSCEND programmes continue to generate readouts, and Lilly has not publicly announced an NDA filing date as of June 21, 2026. For a detailed regulatory timeline, see our retatrutide approval status tracker; for Dubai market context, see Dubai research guide.

All retatrutide materials supplied by Remy Peptides are strictly for in-vitro laboratory research and are not intended for human or veterinary administration. This guide is about supplier evaluation and research-use procurement, not medical dosing or treatment. Ongoing preclinical and clinical research is still defining the full profile of this investigational peptide across obesity and metabolic research settings.

Retatrutide Product Formats Available in Dubai

This table spotlights the two proof-led prefilled pen formats used for price and COA comparison on this guide. The 30mg pen is the flagship batch-proof format, while the 20mg pen offers a lower upfront entry point with the highest published pen HPLC on the site. Both are Janoshik-verified, dispatched cold-chain, and supplied strictly for in-vitro laboratory research. For the full six-format catalogue, including current 10mg vial availability status, compare the Retatrutide UAE format matrix.

UAE Regulatory Landscape for Research Peptides

Understanding the regulatory framework is essential before sourcing any research compound in the UAE. Retatrutide occupies a specific position within this framework that researchers should be aware of.

Under MoHAP Circular 17/2022, research-grade peptides that are clearly labelled for in-vitro laboratory use and are not marketed for human consumption operate within the existing regulatory framework. Retatrutide is not classified as a controlled substance in any UAE jurisdiction. As an investigational compound without regulatory approval from the FDA or any other authority, it falls outside the scope of scheduled pharmaceutical regulations.

This is distinct from approved prescription GLP-1 medications like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro), which are regulated pharmaceuticals available only through licensed pharmacies with a prescription. In the UAE, interest in GLP-1 medications has grown alongside obesity-management demand and broader attention on newer weight-loss medications. Retatrutide will not be available through clinical channels until after FDA approval and subsequent MoHAP regulatory review.

The requirement is that all materials carry “For Research Use Only” labelling and that no therapeutic claims are made. For a broader overview of peptide legality across jurisdictions, see our peptide legality guide, our Dubai-specific legality brief, our peptides in the UAE overview, and the UAE, GCC and Lebanon guide hub if the search has regional intent beyond Dubai.

If you need the molecule-level routing layer before screening suppliers, open the Retatrutide Research Hub. It separates mechanism, approval status, published trial design, Dubai availability, and trial milestones so this checklist can stay focused on proof and supplier quality.

What to Look for in a Retatrutide Supplier

Not all peptide suppliers maintain equivalent quality standards. The following criteria separate verified research-grade sources from unreliable ones. Applying this checklist before placing any order protects both research integrity and laboratory budgets.

Third-Party Purity Testing

The single most important indicator of a legitimate supplier is independent purity verification. Demand HPLC (High-Performance Liquid Chromatography) analysis conducted by a third-party laboratory — not an in-house test. A minimum threshold of 99% purity is standard for research-grade retatrutide. Remy Peptides uses Janoshik Analytical, an independent Czech laboratory widely recognised in the peptide research community, and publishes full test results for each released Retatrutide batch.

Certificate of Analysis

A genuine COA is batch-specific, dated, and includes quantitative HPLC data with retention times and peak area percentages. Generic specification sheets or undated documents are insufficient. Every Remy Peptides batch COA is published at /coa/ with the batch number, test date, and complete analytical results. Batch RETP002 is verified at 99.262% purity. For a field-by-field reading of HPLC purity, assay, LC-MS identity, endotoxin, TFA, and heavy metals, use the Peptide COA Guide.

Format and Delivery

Retatrutide can appear in several supplier formats: prefilled pen, lyophilised powder vial, and raw powder. For laboratory research requiring repeatable measurement, prefilled pens reduce reconstitution variables and handling risk. In Dubai’s climate — where summer temperatures regularly exceed 45°C — tracked cold-chain delivery is not optional. Insulated, temperature-monitored packaging is essential to preserve peptide integrity from dispatch to laboratory receipt. For a complete breakdown of pen mechanics and hardware limits, see our retatrutide pen guide.

Pricing Transparency

Reputable suppliers publish pricing in local currency (AED) without hidden fees for shipping, cold-chain packaging, or COA documentation. Volume discounts should be clearly tiered. Remy Peptides publishes tiered pricing for larger orders through its bulk research-volume RFQ. Any supplier that cannot provide upfront pricing or requires negotiation before revealing costs warrants caution.

Prefilled Pen vs Vial: Which Format for Dubai Research?

Format selection directly impacts measurement repeatability, handling risk, and workflow efficiency in the laboratory. The following comparison covers the key variables researchers should evaluate.

For many Dubai-based lab workflows, the prefilled pen format offers stronger measurement repeatability and reduces the primary handling variable associated with powder reconstitution. The sealed pen system also provides better thermal stability during last-mile delivery — a significant consideration in the UAE climate.

For detailed guidance on pen mechanics and click-based measurement, see our retatrutide pen guide. For storage references across all formats, see our peptide stability and storage guide.

Retatrutide Weight-Loss Mechanism vs Other GLP-1 Research Context

The key differentiator for retatrutide is its triple-receptor mechanism. Approved GLP-1 medicines and next-generation research compounds vary in the receptors they engage; this comparison is included for literature context, not as clinical substitution or purchase guidance.

• Semaglutide (Ozempic in Dubai / Wegovy): Single receptor (GLP-1 only) — body-weight endpoints reported in separate clinical trials
• Tirzepatide (Mounjaro in Dubai): Dual receptor (GLP-1 + GIP) — body-weight endpoints reported in separate clinical trials
• Retatrutide: Triple receptor (GLP-1 + GIP + glucagon) — 24.2% mean body-weight endpoint in Phase 2 data; TRIUMPH-1 Phase 3 topline: 28.3% at 80 weeks (12 mg, May 21, 2026)

These are separate research datasets, not head-to-head purchasing claims. For a full breakdown of mechanism and published trial-design context, see our Retatrutide vs Tirzepatide vs CagriSema comparison.

Price Sanity Checks Before You Order

A realistic price band is a supplier-vetting signal, not a shopping list. The live retatrutide UAE price list is maintained on the main catalogue; the reference figures below exist so you can spot quotes that fall suspiciously outside the verified band.

• 30mg pen: AED 1,600 single, AED 1,450/pen at 2-pack, AED 1,300/pen at 5+ pack
• 20mg pen: AED 1,200 single, AED 1,100/pen at 2-pack, AED 1,000/pen at 5+ pack

Volume-tier pricing at Remy Peptides reduces the effective per-milligram cost on the 30mg pen — AED 1,600 (AED 53/mg) for a single pen, AED 2,900 (AED 48/mg) at the 2-pack tier, and AED 6,500 (AED 43/mg) at the 5+ tier. The 20mg pen runs AED 60/mg single, AED 55/mg at 2-pack, and AED 50/mg at 5+ pack. This provides verified cost-per-milligram transparency for HPLC-tested retatrutide in the UAE market.

Promotional bundle pricing is inactive. Compare prices using only the units listed in the paid tiers above.

Red flag: Prices significantly below AED 1,400 per 30mg pen should trigger due diligence. Sub-market pricing typically indicates compromised purity, lack of third-party testing, or substituted compounds. Always request a batch-specific COA before purchasing from any supplier.

Use this page as the guide layer, then verify live product details on the retatrutide price list for Dubai and the UAE, the Retatrutide 30mg Pen page, and the Retatrutide 20mg Pen page.

Dubai Cost per Milligram

For laboratories planning multi-week in-vitro work, the total cost per milligram is often more relevant than the per-pen price. Volume tiers reduce the effective per-mg figure rather than just the unit price, which matters when a study requires multiple units.

• Single pen order: AED 1,600 for 30mg — AED 53/mg
• 2-pack order: AED 2,900 for 60mg — AED 48/mg
• 5+ pack order: AED 6,500 for 150mg — AED 43/mg

The volume-tier structure is designed to support longer research procurement plans without requiring repeated single-unit orders at premium rates. It is not dosing or administration guidance.

Same-Day & Next-Day Retatrutide Delivery in the UAE

All retatrutide orders dispatch from the Remy Peptides Dubai facility in insulated cold-chain packaging. Delivery windows vary by emirate, with Dubai offering same-day arrival when the order is confirmed before the cutoff.

• Dubai: Same-day delivery (order by 4 PM) — DIFC, Downtown, JBR, JLT, Business Bay, Dubai Marina, Dubai Hills
• Abu Dhabi: Next-day delivery
• Sharjah: Next-day delivery
• Ajman: Next-day delivery
• Other emirates: Next-day delivery — Ras Al Khaimah, Umm Al Quwain, Fujairah

Insulated, temperature-monitored packaging is critical when UAE summer ambient temperatures exceed 45°C. Cold-chain integrity from dispatch to laboratory receipt is the documented Remy Peptides standard regardless of order size or destination emirate.

Procurement Verification Steps for Dubai Research

Once a supplier passes the screen above, a research procurement workflow stays compliance-first. The sequence below is structured around verification rather than transaction speed.

1. Confirm research-only labelling: All retatrutide materials must carry “For Research Use Only” labelling consistent with MoHAP Circular 17/2022. No therapeutic, administration, or clinical claims should appear on packaging or supplier copy.
2. Match the COA to the unit: Cross-reference the batch number on the pen or vial against the published COA before agreeing to any pricing. Remy Peptides publishes each released Retatrutide batch at /coa/.
3. Choose the format that fits the lab plan: Review the retatrutide pen guide and stability and storage guide before fixing pack size. Live tiers and dispatch windows are listed on the Dubai price and delivery reference.
4. Calculate price from paid units only: Use AED 53/mg single, AED 48/mg at 2-pack, and AED 43/mg at 5+ pack for 30mg pens.
5. Confirm cold-chain handling: Dubai summer ambient temperatures regularly exceed 45°C. Insulated, temperature-monitored packaging with same-day Dubai or next-day inter-emirate dispatch is the documented Remy Peptides standard. Abu Dhabi and Sharjah use next-day cold-chain dispatch.
6. Open a verification channel: Use /contact-verify/ for documentation requests, institutional procurement, or batch questions before any payment is discussed.

Material is supplied strictly for in-vitro laboratory research. For a single consolidated view of Retatrutide UAE supply across all emirates, use the UAE supply reference.

How to Use This Buying Guide

Use the guide in this order: start with price, confirm the COA, check the format, then move to delivery and official contact verification. The linked Remy pages are evidence sources, not shortcuts around the verification steps.

1. Start with the price table: Compare the 30mg and 20mg pen tiers above, then cross-check the full six-format matrix at Retatrutide UAE pricing.
2. Open the batch proof: Match the product format to the correct report in the COA library, especially RETP002 for the 30mg pen and RET-20-C-2604-001 for the 20mg pen.
3. Check format math: Use the calculator, pen guide, and clicks guide before deciding which paid tier fits the lab plan.
4. Verify the official route: Use contact verification before sending funds, then use the relevant product page or order page only after the checks above are complete.